Precious cargo TING XU’S NEW NANOCARRIER DELIVERS DRUGS DIRECTLY TO TUMORS, THEN DISASSEMBLES AND SAFELY LEAVES THE BODY The use of nanoparticles to deliver chemotherapy drugs to cancerous tumors started in the 1980s. Since then, researchers have experimented with different styles of nanocarriers to hit upon the right combination of size and materials to release drugs to the heart of tumors without punishing side effects. Too large, and the nanocarriers cannot penetrate a tumor cell for a direct hit. Too small, and they get lost in the bloodstream before finding the target. Besides, introducing a material into the body that cannot get out again may cause side effects that negate the benefits of treatment. Researcher Ting Xu has conceived of a solution that greatly advances the science and offers promising clinical implications for cancer patients and for sufferers of other diseases and conditions. Using a soap-like material whittled down to a neat 15 nm size, Xu has developed a nanocarrier that slips into a tumor cell to release treatment where it can have its most powerful effect. The nanocarrier then dissolves into small bits that pass quickly and safely through the body without toxic accumulation. “I look at this as a beautiful marriage of basic science and real-world application,” says Xu, who holds faculty appointments in materials science and engineering and chemistry. TEXT BY DANIEL MCGLYNN , PHOTO BY NOAH BERGER, ILLUSTRATIONS BY JASON LEE
Working with both biological and synthetic components, Ting Xu is combining the best of different drug delivery methods to create a more effective cancer treatment. Controlling all of the nanocarrier’s phases, from assembly to disassembly, has practical implications for other kinds of drug delivery, including vaccinations and treating chronic diseases.
The Fall 2012 issue of Berkeley Engineer features the latest advances in brain-machine interfaces, nano-sized drug carriers, microgrids in I...